RETRACTION: AK4 Promotes the Progression of HER2-Positive Breast Cancer by Facilitating Cell Proliferation and Invasion
[This retracts the article DOI: 10.1155/2019/8186091.].
RETRACTION: Kinesin Family Member 18A (KIF18A) Contributes to the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells In Vitro and In Vivo
[This retracts the article DOI: 10.1155/2019/6383685.].
RETRACTION: Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer
[This retracts the article DOI: 10.1155/2018/4272064.].
RETRACTION: The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer
[This retracts the article DOI: 10.1155/2019/5380197.].
Plasma microRNA-320c as a Potential Biomarker for the Severity of Knee Osteoarthritis and Regulates cAMP Responsive Element Binding Protein 5 (CREB5) in Chondrocytes
Osteoarthritis (OA) is a commonly known prevalent joint disease, with limited therapeutic methods. This study aimed to investigate the expression of plasma microRNA-320c (miR-320c) in patients with knee OA and to explore the clinical value and potential mechanism of miR-320c in knee OA.
RETRACTION: β-Elemene Promotes Apoptosis Induced by Hyperthermia via Inhibiting HSP70
[This retracts the article DOI: 10.1155/2022/7313026.].
RETRACTION: KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo
[This retracts the article DOI: 10.1155/2019/4824902.].
JAK2 as Predictor of Therapeutic Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib
Chronic myeloid leukemia (CML) or chronic granulocytic leukemia is a myeloproliferative neoplasm indicated by the presence of the Philadelphia (Ph+) chromosome. First-line tyrosine kinase inhibitor, imatinib, is the gold standard for treatment. However, there has been known unresponsiveness to treatment, especially due to the involvement of other genes, such as the Janus kinase 2 (JAK2) gene. This study aimed to evaluate the relationships between JAK2 levels and complete hematological response (CHR), as well as early molecular response (EMR) after 3 months of imatinib treatment in patients with chronic phase CML.
RETRACTION: KIF23 Promotes Gastric Cancer by Stimulating Cell Proliferation
[This retracts the article DOI: 10.1155/2019/9751923.].
RETRACTION: Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma
[This retracts the article DOI: 10.1155/2022/6400227.].
RETRACTION: Identification of Novel Subtypes in Lung Adenocarcinoma: Evidence from Gene Set Variation Analysis in Tumor and Adjacent Nontumor Samples
[This retracts the article DOI: 10.1155/2022/2602812.].
RETRACTION: Identification of Inflammatory Gene in the Congenital Heart Surgery Patients following Cardiopulmonary Bypass via the Way of WGCNA and Machine Learning Algorithms
[This retracts the article DOI: 10.1155/2023/5493415.].
RETRACTION: TRIM29 as a Novel Biomarker in Pancreatic Adenocarcinoma
[This retracts the article DOI: 10.1155/2014/317817.].
Impact of rs599839 Polymorphism on Coronary Artery Disease Risk in Saudi Diabetic Patients
Coronary artery diseases may be affected by several genetic and nongenetic factors. Single-nucleotide polymorphism (SNP) rs599839 and type 2 diabetes mellitus (T2DM) can affect the occurrence and severity of coronary artery disease (CAD).
RETRACTION: Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Metastasis via the miR-155-5p/FGF7 Axis and Predicts Poor Prognosis in Gastric Cancer
[This retracts the article DOI: 10.1155/2020/8140989.].
Corrigendum to "Fluvastatin Upregulates the Subunit of CaV1.2 Channel Expression in Vascular Smooth Muscle Cells via RhoA and ERK/p38 MAPK Pathways"
[This corrects the article DOI: 10.1155/2014/237067.].
RETRACTION: MCOLN1 Promotes Proliferation and Predicts Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma
[This retracts the article DOI: 10.1155/2019/9436047.].
Significance of Estrogen/Progesterone Receptor Expression in Metaplastic Breast Carcinoma
Metaplastic breast carcinoma (MBC) is a rare subgroup of breast neoplasms associated with adverse outcomes because of its aggressive nature. Typically, MBCs show triple-negative hormone receptor (HR) status. Determining the HR status of breast cancer is an integral part because it is an important prognostic factor and helps in the treatment course of the disease. This study aimed to determine the HR status of MBC, its significance, and its association with various clinicopathological parameters.
RETRACTION: HuR Promotes the Progression of Gastric Cancer through Mediating CDC5L Expression
[This retracts the article DOI: 10.1155/2022/5141927.].
Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves
Lung cancer ranks first among malignant tumors worldwide and is a leading cause of cancer-related mortality in both men and women. Combining tumor marker testing is a strategy to screen individuals at high risk of pulmonary cancer and minimize pulmonary cancer mortality. Therefore, tumor marker screening is crucial. In this study, we analyzed combinations of tumor markers for lung cancer screening using receiver operating characteristic (ROC) curve analysis.
RETRACTION: Expression of miR-155 in Serum Exosomes in Children with Epilepsy and Its Diagnostic Value
[This retracts the article DOI: 10.1155/2022/7979500.].
